1Department of Immunology, School of Medicine,UConn Health, 2Center for Molecular Discovery,University of New Mexico Health Sciences Center, 3Comprehensive Cancer Center,University of New Mexico Health Sciences Center, 4Department of Pathology,University of New Mexico Health Sciences Center, 5Autophagy, Inflammation, & Metabolism (AIM) Center,University of New Mexico
Este protocolo descreve um método de triagem de alto rendimento baseado em citometria de fluxo para identificar drogas de moléculas pequenas que inibem a ativação de integrinas β2 em neutrófilos humanos.
